The role of academic pharmacy in tobacco cessation and control

American Journal of Pharmaceutical Education

Volumn 77, Issue 5, 2013, Pages

  McBane, Sarah E ^a   Corelli, Robin L ^b   Albano, Christian B ^c   Conry, John M ^d   Della Paolera, Mark A ^e   Kennedy, Amy K ^f   Jenkins, Antoine T ^g   Hudmon, Karen Suchanek ^h  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Pharmaceutical Sciences   (United States)

^d ST JOHN'S UNIVERSITY   (United States)

^e PACIFIC UNIVERSITY   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g CHICAGO STATE UNIVERSITY   (United States)

^h PURDUE UNIVERSITY   (United States)

Author keywords

Academic pharmacy; Policy; Public health; Smoking; Tobacco

Indexed keywords

ACADEMIC PHARMACY; ARTICLE; ATTITUDE TO HEALTH; CLINICAL COMPETENCE; CURRICULUM; EDUCATION; HEALTH PERSONNEL ATTITUDE; HUMAN; METHODOLOGY; PATIENT ADVOCACY; POLICY; PROFESSIONAL STANDARD; PUBLIC HEALTH; SCHOOL; SMOKING; SMOKING CESSATION; TEACHING; TOBACCO; TOBACCO DEPENDENCE; UNIVERSITY; PREVENTION AND CONTROL; PROCEDURES; TOBACCO USE DISORDER;

ACADEMIC PHARMACY; POLICY; PUBLIC HEALTH; SMOKING; TOBACCO;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; CURRICULUM; EDUCATION, PHARMACY; FACULTY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PATIENT ADVOCACY; PRECEPTORSHIP; PROFESSIONAL ROLE; PUBLIC HEALTH; SCHOOLS, PHARMACY; SMOKING; SMOKING CESSATION; TEACHING; TOBACCO USE DISORDER;

EID: 84878973846     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: 10.5688/ajpe77593     Document Type: Article

References (67)

1. US Department of Health and Human Services. The Health Consequences of Smoking: Cancer. A Report of the Surgeon General. Rockville, MD: Public Health Service, Office on Smoking and Health; 1982.
2. Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57 (45):1226-1228.
3. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. Br Med J. 2004;328(7455):1519.
4. Centers for Disease Control and Prevention. Cigarette smoking-attributable morbidity-United States, 2000. MMWR Morb Mortal Wkly Rep. 2003;52(35):842-844.
5. Centers for Disease Control and Prevention. Current cigarette smoking among adults-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(44):889-894.
6. Campaign for Tobacco-Free Kids. Spending vs. tobacco company marketing. http://www.tobaccofreekids.org/research/factsheets/pdf/0201.pdf. Accessed May 26, 2013.
7. Campaign for Tobacco-Free Kids. State-specific estimates of tobacco company marketing expenditures: 1998-2010. http://www. tobaccofreekids.org/research/factsheets/pdf/0271.pdf. Accessed May 26, 2013.
8. US Department of Health and Human Services. Healthy people 2020: tobacco use. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicId541. Accessed May 26, 2013.
9. Centers for Disease Control and Prevention. Best Practices for Comprehensive Tobacco Control Programs-2007. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2007.
10. Centers for Disease Control and Prevention. Quitting smoking among adults-United States, 2001-2010. MMWR Morb Mortal Wkly Rep. 2011;60(44):1513-1519.
11. US Department of Health and Human Services. Tobacco Use Among US Racial/Ethnic Minority Groups - African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention; 1998.
12. Koop CE. Pharmacists' 'Helping Smokers Quit' program. Am Pharm. 1986;NS26(7):25-33.
13. Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2004(1):CD003698.
14. Dent LA, Harris KJ, Noonan CW. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy. 2007;27(7):1040-1051.
15. McGhan WF, Smith MD. Pharmacoeconomic analysis of smoking-cessation interventions. Am J Health-Syst Pharm. 1996; 53(1):45-52.
16. Tran MT, Holdford DA, Kennedy DT, Small RE. Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice. Pharmacotherapy. 2002;22(12): 1623-1631.
17. Hudmon KS, Prokhorov AV, Corelli RL. Tobacco cessation counseling: pharmacists' opinions and practices. Patient Educ Couns. 2006;61(1):152-160.
18. Corelli RL, Kroon LA, Chung EP, et al. Statewide evaluation of a tobacco cessation curriculum for pharmacy students. Prev Med. 2005;40(6):888-895.
19. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2008.
20. Hudmon KS, Bardel K, Kroon LA, Fenlon CM, Corelli RL. Tobacco education in US schools of pharmacy. Nicotine Tob Res. 2005;7(2):225-232.
21. Carson KV, Verbiest ME, Crone MR, et al. Training health professionals in smoking cessation. Cochrane Database Syst Rev. 2012;5:CD000214.
22. Bonniot Saucedo C, Schroeder SA. Simplicity sells: making smoking cessation easier. Am J Prev Med. 2010;38(3 Suppl):S393-S396.
23. Schroeder SA. What to do with a patient who smokes. JAMA. 27 2005;294(4):482-487.
24. Prokhorov AV, Hudmon KS, Marani S, et al. Engaging physicians and pharmacists in providing smoking cessation counseling. Arch Intern Med. 2010;170(18):1640-1646.
25. Purcell JL, Farris KB, Aquilino ML. Feasibility of brief smoking cessation intervention in community pharmacies. J Am Pharm Assoc. 2006;46(5):616-618.
26. Baggarly SA, Jenkins TL, Biglane GC, Smith GW, Smith CM, Blaylock BL. Implementing a referral to telephone tobacco cessation services in Louisiana community pharmacies: a pilot study. Ann Pharmacother. 2010;44(9):1395-1402.
27. Hoch MA, Hudmon KS, Lee L, et al. Pharmacists' perceptions of participation in a community pharmacy-based nicotine replacement therapy distribution program. J Community Health. 2012;37(4): 848-854.
28. Patwardhan PD, Chewning BA. Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. J Am Pharm Assoc. 2012;52(4):507-514.
29. Carpenter KM, Carlini BH, Painter I, Mikko AT, Stoner SA. Refer2Quit: Impact of Web-based skills training on tobacco interventions and quitline referrals. J Cont Educ Health Prof. 2012; 32(3):187-195.
30. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Washington, DC: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
31. Association for the Treatment of Tobacco Use and Dependence. Core competencies for tobacco treatment specialists. April, 2005. http://attudaccred.org/extras/attud/ATTUD-Core-Competencies.pdf. Accessed May 26, 2013.
32. Rx for Change: Clinician-Assisted Tobacco Cessation. University of California, San Francisco, Schools of Pharmacy and Medicine. http://rxforchange.ucsf.edu. Accessed May 26, 2013.
33. Hudmon KS, Addleton RL, Vitale FM, Christiansen BA, Mejicano GC. Advancing public health through continuing education of health care professionals. J Contin Educ Health Prof. 2011; 31(Suppl 1):S60-S66.
34. Corelli RL, Fenlon CM, Kroon LA, Prokhorov AV, Hudmon KS. Evaluation of a train-the-trainer program for tobacco cessation. Am J Pharm Educ. 2007;71(6):Article 109.
35. Geller AC, Zapka J, Brooks KR, et al. Tobacco control competencies for US medical students. Am J Public Health. 2005; 95(6):950-955.
36. Hudmon KS, Corelli RL, Kroon LA. Dissemination and implementation of a shared tobacco cessation curriculum for pharmacy schools. Presented at: American Association of Colleges of Pharmacy Annual Meeting, Kissimmee, FL, July 2012.
37. Schmelz AN, Nixon B, McDaniel A, Hudmon KS, Zillich AJ. Evaluation of an online tobacco cessation course for health professions students. Am J Pharm Educ. 2010;74(2):Article 36.
38. Maynard A, Metcalf M, Hance L. Enhancing readiness of health profession students to address tobacco cessation with patients through online training. Int J Med Educ. 2012;3:57-62.
39. Cook DA. If you teach them, will they learn: why medical education needs comparative effectiveness research. Adv Health Sci Educ. 2012;17:305-310.
40. Martin BA, Bruskiewitz RH, Chewning BA. Effect of a tobacco cessation continuing professional education program on pharmacists' confidence, skills, and practice-change behaviors. J Am Pharm Assoc. 2010;50(1):9-16.
41. Waheedi M, Al-Tmimy AM, Enlund H. Preparedness for the smoking cessation role among health sciences students in Kuwait. Med Princ Pract. 2011;20(3):237-243.
42. American Pharmacists Association. Code of ethics for pharmacists. http://www.pharmacist.com/code-ethics. Accessed May 26, 2013.
43. Hudmon KS, Fenlon CM, Corelli RL, Prokhorov AV, Schroeder SA. Tobacco sales in pharmacies: time to quit. Tob Control. 2006; 15(1):35-38.
44. Kotecki JE, Hillery DL. A survey of pharmacists' opinions and practices related to the sale of cigarettes in pharmacies-revisited. J Community Health. 2002;27(5):321-333.
45. Hudmon KS, Hussar DA, Fenlon CM, Corelli RL. Pharmacy students' perceptions of tobacco sales in pharmacies and suggested strategies for promoting tobacco-free experiential sites. Am J Pharm Educ. 2006;70(4):Article 75.
46. Smith DM, Hyland AJ, Rivard C, Bednarczyk EM, Brody PM, Marshall JR. Tobacco sales in pharmacies: a survey of attitudes, knowledge and beliefs of pharmacists employed in student experiential and other worksites in Western New York. BMC Res Notes. 2012;5:413.
47. Chai T, Karic A, Fairman M, Baez K, Hudmon KS, Corelli RL. Tobacco and alcohol sales in community pharmacies: Policy statements from US professional pharmacy associations. Presented at: American Society of Health-System Pharmacists Midyear Meeting & Exhibition, Las Vegas, NV, December, 2012.
48. Leslie SW, Beck DE, Ives TJ, et al. Final Report of the 2002-2003 Bylaws and Policy Development Committee. Am J Pharm Educ. 2003;67(3):Article S04.
49. American Pharmacists Association. Report of the 1971 APhA House of Delegates. J Am Pharm Assoc. 1971;NS(11):270.
50. American Pharmacists Association. Current adopted APhA policy statements: 2010 discontinuation of the sale of tobacco products in pharmacies and facilities that include pharmacies. http://www. pharmacist.com/sites/default/files/files/HOD_APhA_Policy_ Manual_0.pdf. Accessed May 26, 2013.
51. Hudmon KS, Corelli RL. ASHP therapeutic position statement on the cessation of tobacco use. Am J Health-System Pharm. 2009;66:291-307.
52. International Pharmaceutical Federation (FIP). FIP statement of policy: the role of the pharmacist in promoting a tobacco free future. http://www.fip.org/www/uploads/database_file.php?id5172&table_id5. Accessed May 26, 2013.
53. American Medical Association. Resolutions of the 2009 AMA annual meeting: Banning tobacco product sales in pharmacies. http://www.ama-assn.org/resources/doc/hod/a-09-resolutions.pdf. Accessed May 26, 2013.
54. Seidenberg AB, Behm I, Rees VW, Connolly GN. Cigarette sales in pharmacies in the USA (2005-2009). Tob Control. 2012; 21(5):509-510.
55. Eule B, Sullivan MK, Schroeder SA, Hudmon KS. Merchandising of cigarettes in San Francisco pharmacies: 27 years later. Tob Control. 2004;13(4):429-432.
56. Corelli RL, Aschebrook-Kilfoy B, Kim G, Ambrose PJ, Hudmon KS. Availability of tobacco and alcohol products in Los Angeles community pharmacies. J Community Health. 2012;37(1): 113-118.
57. Kroon LA, Corelli RL, Roth AP, Hudmon KS. Public perceptions of the ban on tobacco sales in San Francisco pharmacies. Tob Control. 2012; e-pub ahead of print.
58. McDaniel PA, Malone RE. Why California retailers stop selling tobacco products, and what their customers and employees think about it when they do: case studies. BMC Public Health. 2011; 11:848.
59. Katz MH. Banning tobacco sales in pharmacies: the right prescription. JAMA. 2008;300(12):1451-1453.
60. Tobacco-free Pharmacies. Tobacco-free Pharmacies: Local Efforts. http://www.tobaccofreerx.org/local_efforts.html. Accessed May 26, 2013.
61. Woodward AC, Henley PP, Wilson DJ. Banning tobacco sales in Massachusetts' pharmacies. J Am Coll Nutr. 2012;31(3):145-148.
62. Tong EK, Strouse R, Hall J, Kovac M, Schroeder SA. National survey of U.S. health professionals' smoking prevalence, cessation practices, and beliefs. Nicotine Tob Res. 2010;12(7):724-733.
63. Sarna L, Bialous SA, Sinha K, Yang Q, Wewers ME. Are health care providers still smoking? Data from the 2003 and 2006/2007 Tobacco Use Supplement-Current Population Surveys. Nicotine Tob Res. 2010;12(11):1167-1171.
64. Meyer R, Farris KB, Zillich A, Aquilino M. Documentation of smoking status in pharmacy dispensing software. Am J Health-System Pharm. 2004;61(1):101-102.
65. Kroon LA. Drug interactions with smoking. Am J Health-System Pharm. 2007;64(18):1917-1921.
66. Bernstein SL, Cabral L, Maantay J, et al. Disparities in access to over-the-counter nicotine replacement products in New York City pharmacies. Am J Public Health. 2009;99(9):1699-1704.
67. Coffman RE, Bratberg JP, Flowers SK, et al. Report of the 2010-2011 Standing Committee on Advocacy: leveraging faculty engagement to improve public policy. Am J Pharm Educ. 2011; 75(10):Article S7.